200
Participants
Start Date
August 12, 2020
Primary Completion Date
November 30, 2028
Study Completion Date
November 30, 2028
Cedrus RB-844 response pad; Adtech Behnke-Fried micro-electrodes; Neurolynx electrophysiology system; Blackrock Cerestim stimulator
Devices listed are components of a single intervention that includes: Record patient responses (Cedrus RB-844), record neuronal activity (Neurolynx) from electrodes (Adtech Behnke-Fried), apply intermittent electrical stimulation (Blackrock Cerestim)
Cedars-Sinai Medical Center, Los Angeles
Johns Hopkins University
OTHER
University of Colorado, Denver
OTHER
University Health Network, Toronto
OTHER
Boston Children's Hospital
OTHER
University of California, Santa Barbara
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
California Institute of Technology
OTHER
Cedars-Sinai Medical Center
OTHER